Astellas Pharma to transfer Intal rights to Sanofi-aventis - News - Manufacturing
Links shared publicly online about this topic.
- 787total visits
Astellas Pharma to transfer Intal rights to Sanofi-aventis - News - Manufacturing
manufacturing.pharmaceutical-business-review.com —
Astellas Pharma is set to transfer the rights to distribute the anti-allergic drug Intal (sodium cromoglycate) to Sanofi-aventis effective on 1 January 2011.
View full resource at manufacturing.pharmaceutical-business-review.com
Tags: Mineral, Sodium, Drug, Pharma, Sanofi-Aventis, Astellas Pharma, News
Most Recently Shared on October 21, 2010 at 1:42 am By:
Astellas Pharma to transfer Intal rights to Sanofi-aventis - News - Manufacturing http://is.gd/gatRD
Advertisement
